Clinical Trial: ALLIANCE A011203

ALLIANCE A011203

Status: Closed

A Randomized Phase II Trial of Tamoxifen Versus Z-Endoxifen HCL in Postmenopausal Women with Metastatic Estrogen Receptor Positive, HER2 Negative Breast Cancer

A011203 is permanently closed to accrual effective May 19, 2017.